Cunningham K S, Veinot J P, Butany J
Department of Pathology, University Health Network, University of Toronto, Toronto, Ontario M5G 2CA, Canada.
J Clin Pathol. 2006 Feb;59(2):121-9. doi: 10.1136/jcp.2005.026443.
The endomyocardial biopsy (EMB) remains the gold standard mode of investigation for diagnosing many primary and secondary cardiac conditions. Through a percutaneous and transvenous route, tissue fragments are generally procured from the right ventricular septum, with very few complications. Widespread use of EMB followed the development of heart transplantation as a means to follow allograft rejection. It has since been useful in helping to diagnose conditions affecting the heart, including cardiomyopathies, myocarditis, infiltrative lesions, arrhythmias, and drug toxicities. The procedure has also been used as a research tool to investigate the natural history of disease and the cardiotoxicity of new medications. This review presents an approach to the evaluation of the EMB, which is particularly directed towards those who may be asked to interpret such biopsies, but are not dedicated cardiovascular pathologists. Through a systematic evaluation of the endocardium, myocardium, interstitium, and intramural vessels, in the context of a complete clinical history, enough information can be deduced to diagnose or exclude specific conditions of clinical value.
心内膜心肌活检(EMB)仍然是诊断许多原发性和继发性心脏疾病的金标准检查方式。通过经皮和经静脉途径,通常从右心室间隔获取组织碎片,并发症极少。随着心脏移植的发展,EMB得到广泛应用,作为监测同种异体移植排斥反应的一种手段。此后,它在帮助诊断影响心脏的疾病方面发挥了作用,包括心肌病、心肌炎、浸润性病变、心律失常和药物毒性。该检查程序还被用作研究工具,以探究疾病的自然史和新药的心脏毒性。本综述介绍了一种评估EMB的方法,特别针对那些可能被要求解读此类活检结果,但并非专门从事心血管病理学的人员。通过在完整临床病史背景下,对心内膜、心肌、间质和壁内血管进行系统评估,可以推断出足够的信息来诊断或排除具有临床价值的特定疾病。